Javitt Jonathan C - Insider Non-Derivative Transactions at NRX Pharmaceuticals, Inc. (NRXP) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 23, 2023, Javitt Jonathan C's relationship to NRX Pharmaceuticals, Inc. (NRXP) is Director,Officer,TenPercentOwner (Chief Scientist), and currently has 14,468,329 shares of Common Stock, par value $0.001 per share, and 446,332 shares of Common Stock.
The the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NRXP insiders.
Data Source: SEC.
Javitt Jonathan C - Insider Non-Derivative Transactions of NRXP Common Stock
Javitt Jonathan C - Insider Non-Derivative Transactions at NRXP
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Aug 24, 2023 | P -- (Common Stock) | 100000 | 0.33 | 446332 |
Aug 23, 2023 | P -- (Common Stock) | 200000 | 0.32 | 346332 |
Dec 15, 2022 | G -- (Common Stock, par value $0.001 per share) | 300000 | 0 | 14468329 |